ONCOLYTICS BIOTECH INC — Director's Dealing 2026

Feb 13, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOLYTICS BIOTECH INC (ONCY)
CIK: 0001129928
Period of Report: 2026-02-12

Reporting Person: Hagerman Allison (VP, Product Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-12	Common Shares	P	10000	$0.8298	Acquired	115059	Direct